Showing results (5041-5050 of 5,597) with videos related to
Sort By:
Pageof 560
Journal of Cancer|September 14, 2017
Chemokine Receptors CXCR4 and CXCR7 are Associated with Tumor Aggressiveness and Prognosis in Extramammary Paget DiseaseKun Chang, Gao-Xiang Li, Yun-Yi Kong, et al.Journal of Cancer|September 14, 2017
A Multi-Center Prospective Study to Validate an Algorithm Using Urine and Plasma Biomarkers for Predicting Gleason ≥3+4 Prostate Cancer on BiopsyMaher Albitar, Wanlong Ma, Lars Lund, et al.Journal of Cancer|September 14, 2017
LHX6, An Independent Prognostic Factor, Inhibits Lung Adenocarcinoma Progression through Transcriptional Silencing of β-cateninJuntang Yang, Fei Han, Wenbin Liu, et al.Journal of Cancer|September 14, 2017
Decreased Overall and Cancer-Specific Mortality with Neoadjuvant Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma Treated by Intensity-modulated Radiotherapy: Multivariate Competing Risk AnalysisJian Zhang, Hao Peng, Lei Chen, et al.Journal of Cancer|September 14, 2017
Correlation between ERG Fusion Protein and Androgen Receptor Expression by Immunohistochemistry in Prostate, Possible Role in Diagnosis and TherapyAmir Hassan Navaei, Beatriz A Walter, Vanessa Moreno, et al.Journal of Cancer|September 14, 2017
Profiling chemotherapy-associated myelotoxicity among Chinese gastric cancer population receiving cytotoxic conventional regimens: epidemiological features, timing, predictors and clinical impactsCi Zhu, Yan Wang, Xicheng Wang, et al.Journal of Cancer|February 28, 2018
The Unknown microRNA Expression of Male Breast Cancer. Similarities and Differences with Female Ductal Carcinoma. Their Role as Tumor BiomarkerMaria J Merino, Sara Gil, Carmen Garcia Macias, et al.Journal of Cancer|February 28, 2018
Recombinant nanocomposites by the clinical drugs of Abraxane® and Herceptin® as sequentially dual-targeting therapeutics for breast cancerShuang Ding, Jian Xiong, Dan Lei, et al.Journal of Cancer|February 28, 2018
Impact of Weight Loss at Presentation on Survival in Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors (EGFR-TKI) Sensitive Mutant Advanced Non-small Cell Lung Cancer (NSCLC) Treated with First-line EGFR-TKILiping Lin, Juanjuan Zhao, Jiazhu Hu, et al.Journal of Cancer|February 28, 2018
Association between NEFL Gene Polymorphisms and Neuroblastoma Risk in Chinese Children: A Two-Center Case-Control StudyQiang Wu, Zhen-Jian Zhuo, Jixiao Zeng, et al.Pageof 560